Approval · United States
Wegovy
U.S. Food and Drug Administration · Jun 4, 2021
Approval record
- Asset
- Semaglutide
- Brand name
- Wegovy
- Generic name
- semaglutide
- Indication
- Obesity
- Jurisdiction
- United States
- Regulator
- U.S. Food and Drug Administration
- Approval date
- Jun 4, 2021
- Company
- Novo Nordisk
Sources
- regulatoryprimary record
FDA approves Wegovy (semaglutide) for chronic weight management
U.S. Food and Drug Administration · FDA News Release · Jun 4, 2021